Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection

Publisher: Bentham Science Publishers

ISSN: 2212-7038

Source: Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol.2, Iss.1, 2015-04, pp. : 79-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract